A factorial Mendelian randomization study to systematically prioritize genetic targets for the treatment of cardiovascular disease

Genevieve M. Leyden, Tom R. Gaunt, Tom G. Richardson
doi: https://doi.org/10.1101/2020.02.16.20023010

Article Information

doi 
https://doi.org/10.1101/2020.02.16.20023010
History 
  • February 20, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Genevieve M. Leyden, BSc1,2,
  2. Tom R. Gaunt, PhD1 and
  3. Tom G. Richardson, PhD1,*
  1. 1MRC Integrative Epidemiology Unit, University of Bristol
  2. 2Bristol Medical School: Translational Health Sciences, University of Bristol
  1. ↵*Corresponding author: Dr. Tom G. Richardson, MRC Integrative Epidemiology Unit, Bristol Medical School (Population Health Sciences), University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom. Tom.G.Richardson{at}bristol.ac.uk
Back to top
Posted February 20, 2020.
Download PDF
Data/Code
Email
A factorial Mendelian randomization study to systematically prioritize genetic targets for the treatment of cardiovascular disease
Genevieve M. Leyden, Tom R. Gaunt, Tom G. Richardson
medRxiv 2020.02.16.20023010; doi: https://doi.org/10.1101/2020.02.16.20023010
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area